- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Options in Newly Diagnosed Glioblastoma
Authors
Keywords
Glioblastoma, Temozolomide, Radiation, Bevacizumab, Treatment, Newly diagnosed, Carmustine polymer wafers
Journal
Current Treatment Options in Neurology
Volume 15, Issue 3, Pages 281-288
Publisher
Springer Nature
Online
2013-04-03
DOI
10.1007/s11940-013-0226-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Optimal management of elderly patients with glioblastoma
- (2012) Normand Laperriere et al. CANCER TREATMENT REVIEWS
- Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival
- (2012) Daniel Orringer et al. JOURNAL OF NEUROSURGERY
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- CLIN-ONGOING CLINICAL TRIALS
- (2012) M. Furuse et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009
- (2012) T. A. Dolecek et al. NEURO-ONCOLOGY
- Does Extent of Resection of a Glioblastoma Matter?
- (2012) Michael A. Vogelbaum NEUROSURGERY
- Brain Tumor Rehabilitation
- (2011) Mary Vargo AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
- Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
- (2011) David A Reardon et al. Future Oncology
- Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours
- (2011) Michelangelo Bartolo et al. JOURNAL OF NEURO-ONCOLOGY
- Treatment of high-grade glioma in children and adolescents
- (2011) T. J. MacDonald et al. NEURO-ONCOLOGY
- Metabolic management of brain cancer
- (2010) Thomas N. Seyfried et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
- (2009) Rachel L. Derr et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
- (2008) B. D. Lawenda et al. JNCI-Journal of the National Cancer Institute
- Safety of anticoagulation use and bevacizumab in patients with glioma
- (2008) Phioanh (Leia) Nghiemphu et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started